搜索临床试验以:bevacizumab erlotinib hydrochloride
总计10156个结果
-
National Cancer Institute (NCI)主动,不招人复发性输卵管癌 | 复发性卵巢癌 | 复发性原发性腹膜癌 | 卵巢透明细胞囊腺癌 | 卵巢子宫内膜样腺癌 | 卵巢浆液性囊腺癌 | 子宫内膜透明细胞腺癌 | 子宫内膜浆液性腺癌 | 复发性子宫体癌 | IIIA 期输卵管癌 AJCC v7 | IIIA 期卵巢癌 AJCC v6 和 v7 | IIIA 期原发性腹膜癌 AJCC v7 | IIIB 期输卵管癌 AJCC v7 | IIIB 期卵巢癌 AJCC v6 和 v7 | IIIB 期原发性腹膜癌 AJCC v7 | IIIC 期输卵管癌 AJCC v7 | IIIC 期卵巢癌 AJCC v6 和 v7 | IIIC 期原发性腹膜癌 AJCC v7 | IV 期输卵管癌 AJCC v6 和 v7 | IV 期卵巢癌 AJCC v6... 及其他条件美国
-
H. Lee Moffitt Cancer Center and Research InstituteArray BioPharma完全的
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)招聘中解剖学 I 期乳腺癌 AJCC v8 | 解剖学 IA 期乳腺癌 AJCC v8 | 解剖学 IB 期乳腺癌 AJCC v8 | 解剖学 II 期乳腺癌 AJCC v8 | 解剖学 IIA 期乳腺癌 AJCC v8 | 解剖学 IIB 期乳腺癌 AJCC v8 | 解剖学 III 期乳腺癌 AJCC v8 | 解剖学 IIIA 期乳腺癌 AJCC v8 | 解剖学 IIIB 期乳腺癌 AJCC v8 | 解剖学 IIIC 期乳腺癌 AJCC v8 | 预后 I 期乳腺癌 AJCC v8 | 预后 IA 期乳腺癌 AJCC v8 | 预后 IB 期乳腺癌 AJCC v8 | 预后 II 期乳腺癌 AJCC v8 | 预后 IIA 期乳腺癌 AJCC v8 | 预后... 及其他条件美国
-
National Cancer Institute (NCI)主动,不招人胰腺导管腺癌 | 复发性胰腺癌 | IV 期胰腺癌 AJCC v6 和 v7 | 胰腺腺泡细胞癌 | 成人实体瘤美国
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Cancer and Leukemia Group B; North Central Cancer Treatment...主动,不招人
-
Progen Pharmaceuticals完全的
-
Bristol-Myers Squibb完全的
-
Institut de Recherches Internationales ServierADIR, a Servier Group company主动,不招人转移性结直肠癌英国, 立陶宛, 法国, 瑞典, 澳大利亚, 拉脱维亚, 西班牙, 波兰, 阿根廷, 奥地利, 巴西, 保加利亚, 捷克语, 丹麦, 爱沙尼亚, 德国, 匈牙利, 爱尔兰, 意大利, 荷兰, 葡萄牙, 罗马尼亚, 俄罗斯联邦, 斯洛伐克, 乌克兰
-
Amsterdam UMC, location VUmc完全的
-
OHSU Knight Cancer InstituteGenentech, Inc.; OSI Pharmaceuticals终止
-
Sarcoma Oncology Research Center, LLCAdvenchen Laboratories, LLC主动,不招人
-
National Cancer Institute (NCI)完全的Trebananib 联合或不联合 Bevacizumab、Pazopanib Hydrochloride、Sorafenib Tosylate 或 Sunitinib Malate 治疗晚期肾癌患者晚期肾细胞癌 | III 期肾细胞癌 AJCC v7 | IV 期肾细胞癌 AJCC v7 | 晚期肉瘤样肾细胞癌美国
-
GlaxoSmithKline完全的
-
KeifeRx, LLCWorldwide Clinical Trials; Life Molecular Imaging GmbH; Sun Pharmaceuticals Industries Limited尚未招聘
-
Peking UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
Finnish Lung Cancer GroupRoche Pharma AG完全的
-
Emory UniversityNational Institutes of Health (NIH)完全的
-
Massachusetts Institute of TechnologyMassachusetts General Hospital尚未招聘
-
National Cancer Institute (NCI)NRG Oncology完全的
-
M.D. Anderson Cancer Center招聘中IB 期肝细胞癌 AJCC v8 | II 期肝细胞癌 AJCC v8 | 可切除的肝细胞癌 | I 期肝细胞癌 AJCC v8 | IA 期肝细胞癌 AJCC v8美国
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的胃食管连接部腺癌 | II期胃癌 | III期胃癌 | 食管鳞状细胞癌 | 胃腺癌 | 食管腺癌 | III期食道癌 | II期食管癌美国
-
People's Hospital of GuangxiLiuzhou Workers Hospital; Cancer Hospital of Guangxi Medical University; First Affiliated Hospital... 和其他合作者尚未招聘
-
The First Affiliated Hospital with Nanjing Medical...The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; Zhongda Hospital 和其他合作者未知
-
Shanghai Ninth People's Hospital Affiliated to...未知
-
Sheba Medical Center完全的
-
Samsung Medical Center完全的Metastatic Melanoma With KIT Aberration大韩民国
-
The First Affiliated Hospital of Zhengzhou UniversityAnyang Tumor Hospital; Luoyang Central Hospital; Nanyang Central Hospital; Sanmenxia Central Hospital 和其他合作者招聘中
-
National Cancer Institute (NCI)主动,不招人卵巢子宫内膜样腺癌 | 原发性腹膜高级别浆液性腺癌 | 输卵管子宫内膜样腺癌 | 铂类耐药输卵管癌 | 铂类耐药原发性腹膜癌 | 卵巢高级别浆液性腺癌 | 铂类耐药卵巢癌 | 输卵管高级别浆液性腺癌美国, 加拿大
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.尚未招聘
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Spanish Lung Cancer Group完全的
-
Translational Oncology Research InternationalSanofi; University of California, Los Angeles; OSI Pharmaceuticals完全的Unresectable Adenocarcinoma of the Esophagus | Metastatic Adenocarcinoma of the Esophagus | Unresectable Adenocarcinoma of Gastric Cardia | Metastatic Adenocarcinoma of Gastric Cardia美国